
Global Next-Generation Biomanufacturing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Next-Generation Biomanufacturing market size will reach US$ million by 2031.
The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.
United States market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Next-Generation Biomanufacturing players cover Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Next-Generation Biomanufacturing Industry Forecast” looks at past sales and reviews total world Next-Generation Biomanufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Next-Generation Biomanufacturing sales for 2025 through 2031. With Next-Generation Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Biomanufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Upstream Biomanufacturing
Downstream Biomanufacturing
Segmentation by Application:
Biopharmaceutical Companies
CMOs/CDMOs
Research Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Thermo Fisher Scientific
Danaher
Eppendorf
Sartorius
GEA Group
bbi-biotech
Esco Group of Companies
Solaris Biotechnology
PBS Biotech
Applikon Biotechnology
Meissner Filtration Products
Shanghai Bailun Biotechnology
Please note: The report will take approximately 2 business days to prepare and deliver.
The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.
United States market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Next-Generation Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Next-Generation Biomanufacturing players cover Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Next-Generation Biomanufacturing Industry Forecast” looks at past sales and reviews total world Next-Generation Biomanufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Next-Generation Biomanufacturing sales for 2025 through 2031. With Next-Generation Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Biomanufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Upstream Biomanufacturing
Downstream Biomanufacturing
Segmentation by Application:
Biopharmaceutical Companies
CMOs/CDMOs
Research Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Thermo Fisher Scientific
Danaher
Eppendorf
Sartorius
GEA Group
bbi-biotech
Esco Group of Companies
Solaris Biotechnology
PBS Biotech
Applikon Biotechnology
Meissner Filtration Products
Shanghai Bailun Biotechnology
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
102 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Next-Generation Biomanufacturing Market Size by Player
- 4 Next-Generation Biomanufacturing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Next-Generation Biomanufacturing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.